APOE4 lab marker · APOE genotype

APOE4 one copy vs two copies: what is the difference?

For APOE 3/4 (one copy of APOE4, "heterozygous"), about 23 to 30 in 100 people develop Alzheimer's disease by age 85. For APOE 4/4 (two copies, "homozygous"), about 51 to 60 in 100. In the general population it is 11 to 14 in 100 (Genin, 2011). Two copies carry more risk, but neither genotype is a diagnosis. These figures are for 3/4 and 4/4 only. 2/4 also has one APOE4 copy and was reported separately.

This is not medical advice. Phoenix educates. A genetic counselor or doctor can advise you.

The two genotypes side by side

Everyone has two copies of the APOE gene, one from each parent. "Heterozygous" means two different versions of a gene, "homozygous" two identical ones (NHGRI). Here, 3/4 is APOE3 plus APOE4, and 4/4 is two APOE4.

The two genotypes side by side
One copy (3/4)Two copies (4/4)General population
Develop Alzheimer's by age 85, menabout 23 in 100about 51 in 100about 11 in 100
Develop Alzheimer's by age 85, womenabout 30 in 100about 60 in 100about 14 in 100

These are lifetime risk estimates from 7,531 people with Alzheimer's and 10,132 controls of European ancestry, combined with US (Rochester) incidence rates (Genin, 2011). Women's estimates are higher than men's in every row.

What about 2/4? A 2/4 genotype also carries one APOE4 copy, but the 23 to 30 in 100 figures above do not apply to it. The Genin paper reports 2/4 as its own genotype group, so read that paper's table for it rather than borrowing the 3/4 numbers.

What the numbers say, and what they do not

  • Two copies raise risk further than one. The authors call the pattern semi-dominant: one copy raises risk, and two copies raise it further (Genin, 2011; MedlinePlus).
  • It is a risk, not a verdict. Even at the higher end, about 40 to 49 in 100 people with two copies do not develop Alzheimer's by 85 (100 minus 51 to 60). MedlinePlus puts it this way: people with the e4 allele inherit an increased risk of Alzheimer's disease, not the disease itself.
  • The estimates move with the data. The same paper recalculated the estimates with French (PAQUID) incidence rates instead of US ones. At 85 that gave 35 in 100 for women with 3/4 and 68 in 100 for women with 4/4. Treat every number here as a range, not a prediction for one person.
  • Earlier onset is possible with either genotype. Splitting the data by age group, the authors found APOE4 is a risk factor for early-onset as well as late-onset Alzheimer's (Genin, 2011). For the risk at each age, see risk by age.

How Phoenix members compare

Among Phoenix members with a known genotype, roughly half carry two copies, and Phoenix's founder, Kevin Tran, carries two. Phoenix's homepage reports 750+ APOE4 carriers and says 89% see improvement in key APOE4 biomarkers within 3 months. Phoenix only earns revenue from your membership, nothing else. Members with one copy and members with two copies are both part of the community.

Which one do you have?

Your genotype is written as a pair, for example 3/4, 2/4 or 4/4. APOE 3/4 meaning explains one copy in detail. If you are unsure what your report says, start with your APOE4 result.

How the gene passes between generations is covered in Is APOE4 inherited? on Field Notes, and the genetic testing and family guide covers talking to relatives.

Apply to join Phoenix (60-day money-back guarantee)

Questions carriers ask

Frequently asked questions.

Is heterozygous or homozygous worse?

Homozygous (two copies, 4/4) carries the higher estimated risk: about 51 to 60 in 100 by age 85, against 23 to 30 in 100 for 3/4 (Genin, 2011).

What do heterozygous and homozygous mean for APOE4?

Heterozygous means two different versions of the gene, here APOE4 plus another version. For 3/4 that other version is APOE3. Homozygous means two APOE4 (4/4). A 2/4 result is also heterozygous.

If I have two copies, will I get Alzheimer's?

Not necessarily. In the Genin estimates, 51 to 60 in 100 develop it by 85, so the others do not. Two copies raise the chance. They do not decide it.

Is one copy of APOE4 much safer than two?

It is lower, not safe: 23 to 30 in 100 is still above the general population's 11 to 14 in 100.

Do men and women have the same risk?

No. The estimates are higher for women in every group: 30 against 23 in 100 for 3/4, and 60 against 51 in 100 for 4/4 (Genin, 2011).

Is this medical advice?

No. Phoenix educates. A genetic counselor or doctor can advise you.